S Nasca

822 total citations
17 papers, 588 citations indexed

About

S Nasca is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, S Nasca has authored 17 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Surgery. Recurrent topics in S Nasca's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). S Nasca is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). S Nasca collaborates with scholars based in France, United Kingdom and Japan. S Nasca's co-authors include B Paillot, A. Fandi, F. Bertheault-Cvitkovic, Y. Bécouarn, Jean‐Luc Raoul, Marc Ychou, Jean‐François Seitz, Philippe Rougier, Michel Ducreux and T.D. Nguyen and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Annals of Oncology.

In The Last Decade

S Nasca

16 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Nasca France 8 407 171 165 78 72 17 588
Martin Oliverius Czechia 14 307 0.8× 257 1.5× 110 0.7× 113 1.4× 76 1.1× 60 669
Nicoletta Ravarino Italy 11 244 0.6× 142 0.8× 82 0.5× 47 0.6× 64 0.9× 25 517
Michael G. Sarr United States 7 647 1.6× 515 3.0× 205 1.2× 94 1.2× 209 2.9× 9 809
Hajime Yokomizo Japan 12 282 0.7× 241 1.4× 129 0.8× 44 0.6× 50 0.7× 121 512
J-L. van Laethem Belgium 8 254 0.6× 265 1.5× 132 0.8× 50 0.6× 49 0.7× 14 520
Ayumu Hosokawa Japan 14 273 0.7× 167 1.0× 225 1.4× 57 0.7× 141 2.0× 89 554
Armando Antinori Italy 15 275 0.7× 326 1.9× 143 0.9× 139 1.8× 93 1.3× 38 684
S. Post Germany 15 127 0.3× 202 1.2× 144 0.9× 91 1.2× 30 0.4× 45 648
Hideki Nishibori Japan 14 334 0.8× 228 1.3× 82 0.5× 73 0.9× 52 0.7× 34 576
Atsushi Ishiguro Japan 14 207 0.5× 162 0.9× 181 1.1× 59 0.8× 35 0.5× 50 567

Countries citing papers authored by S Nasca

Since Specialization
Citations

This map shows the geographic impact of S Nasca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Nasca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Nasca more than expected).

Fields of papers citing papers by S Nasca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Nasca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Nasca. The network helps show where S Nasca may publish in the future.

Co-authorship network of co-authors of S Nasca

This figure shows the co-authorship network connecting the top 25 collaborators of S Nasca. A scholar is included among the top collaborators of S Nasca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Nasca. S Nasca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Borget, Isabelle, Anne Aupérin, Jean‐Pierre Pignon, et al.. (2006). Cost-Effectiveness Analysis of First-Line Chemotherapies in Metastatic Colorectal Cancer. Oncology. 71(1-2). 40–48. 3 indexed citations
2.
Conroy, Thierry, B Paillot, Éric François, et al.. (2005). Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study. Journal of Clinical Oncology. 23(6). 1228–1236. 173 indexed citations
4.
Seitz, J. F., Jaafar Bennouna, B Paillot, et al.. (2002). Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients. Annals of Oncology. 13(7). 1072–1079. 31 indexed citations
5.
Strady, C., et al.. (2000). Carcinomatous meningitis and solid tumours.. Oncology Reports. 7(1). 203–7. 14 indexed citations
6.
Bennouna, Jaafar, J.F. Seitz, B Paillot, et al.. (1999). ‘Tomudex’ (raltitrexed) plus oxaliplatin (Eloxatin) in previously untreated metastatic colorectal cancer (MCRC) patients: an active combination. European Journal of Cancer. 35. S75–S75. 3 indexed citations
7.
Bécouarn, Y., Marc Ychou, Michel Ducreux, et al.. (1998). Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.. Journal of Clinical Oncology. 16(8). 2739–2744. 247 indexed citations
8.
Nasca, S, et al.. (1997). Early death during initial chemotherapy of squamous cell carcinoma of the oro- or hypopharynx.. PubMed. 17(1B). 647–51. 1 indexed citations
9.
Nasca, S, et al.. (1992). Microbial Contamination of Enteral Feeding Tubes Occurring During Nutritional Treatment. Journal of Parenteral and Enteral Nutrition. 16(6). 552–557. 21 indexed citations
10.
Bogomoletz, Wladimir V., et al.. (1988). Mucin histochemistry of heterotopic gastric mucosa of the upper esophagus in adults: Possible pathogenic implications. Human Pathology. 19(11). 1301–1306. 21 indexed citations
11.
Fornage, Bruno D., et al.. (1987). Sonographic detection and three-dimensional localization of a metallic foreign body in soft-tissues in a dog. British Veterinary Journal. 143(3). 278–282. 7 indexed citations
12.
Coninx, P, et al.. (1986). [Sequential trials in initial chemotherapy of advanced tumors of the upper aero-digestive system. Cis-diamminedichloroplatinum (DDP) versus DDP-etoposide (VP16)].. PubMed. 73(1). 85–8. 3 indexed citations
13.
Nasca, S, et al.. (1982). Phase I study of SOAz.. PubMed. 66(12). 2039–42. 2 indexed citations
14.
Nasca, S, et al.. (1975). Secretin effect on gastrin, gastric secretion in dogs with chronic antral stimulation. American Journal of Physiology-Legacy Content. 228(6). 1775–1781. 8 indexed citations
15.
Chariot, J, Thérèse Lehy, S Nasca, & M Dubrasquet. (1975). [Effects of prolonged hypergastrinia on the rat pancreas].. PubMed. 7(3). 221–36. 1 indexed citations
16.
Lehy, Thérèse, Amélie Bonnefond, M Dubrasquet, et al.. (1973). Comparative Effects of Antrocolic Transposition and Antrectomy on Fundic Mucosa and Acid Secretion of the Rat. Gastroenterology. 64(3). 421–428. 47 indexed citations
17.
Nasca, S, et al.. (1970). [Combined secretin, cholecystokinin and B.S.F. test in the differential diagnosis of icterus].. PubMed. 31(3). 257–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026